India, Oct. 22 -- Bengaluru-based Leucine Rich Bio, a pioneer in genomics and biotechnology, has announced the launch of the BugSpeaks Vaginal Microbiome Test.

The test marks the first vaginal microbiome diagnostic available across South and Middle East Asia, representing a significant advancement in preventive women's healthcare.

The launch builds on the company's established portfolio, which includes the BugSpeaks Gut Microbiome Test and Facial Skin Microbiome Test.

Leucine Rich Bio is now extending its precision multi-omics capabilities to female reproductive and urogenital health, an area that has seen significant diagnostic gaps for decades.

Women's reproductive and urogenital health has historically depended on traditional cultu...